Weight Management Program

Have you been struggling with being overweight

Are you struggling with being overweight and have tried dieting and exercising without success; well, you are not alone; according to the World Health Organization, "43% of adults aged 18 years and over are overweight, and 16% are living with obesity". Worldwide, adult obesity has more than doubled since 1990, and adolescent obesity has quadrupled. The National Institute of Health (NIH) also posted alarming statistics, with Nearly 1 in 3 adults (30.7%) being overweight and More than 2 in 5 adults (42.4%) having obesity.

Weight management is crucial for overall health, as maintaining a healthy weight reduces the risk of numerous chronic diseases. Obesity has been steadily rising and is a significant risk factor for conditions such as heart disease, which is the leading cause of death globally, as well as type 2 diabetes, affecting over 37 million Americans. Additionally, obesity increases the likelihood of high blood pressure, stroke, certain cancers, and joint problems like osteoarthritis. Studies show that even a 5–10% reduction in body weight can significantly improve blood sugar levels, cholesterol, and overall cardiovascular health. Managing weight through a balanced diet, regular exercise, and healthy lifestyle choices is essential for preventing these serious health complications and improving longevity.

Now, losing weight is more feasible and affordable without subjecting yourself to the risk of a surgical procedure such as a gastric bypass or a gastric sleeve.

A cutting-edge medication treatment called GLP-1 receptor agonists can help you lose the access weight and reduce your risk of having high blood pressure, stroke, certain cancers, and joint problems like osteoarthritis. Of course, a balanced diet, regular exercise, and healthy lifestyle choices are always recommended and can give better and faster results.

The GLP-1 receptor agonists, such as Mounjaro and Ozempic, are some of the latest interventions to treat obesity. They were originally developed for the treatment of type 2 diabetes and found to be an effective treatment for reducing weight and obesity.

For instance, Semaglutide (marketed as Ozempic or Wegovy) has demonstrated an average weight loss of approximately 15% over 68 weeks in clinical trials. Similarly, Tirzepatide (Mounjaro or Zepbound), a dual GLP-1 and GIP receptor agonist, has shown even greater efficacy, with participants achieving up to 20.9% weight loss over 72 weeks.

These medications work by mimicking hormones that regulate appetite and food intake, offering promising options for individuals seeking to manage their weight and associated health risks.

This is the ‘before’ that leads to an amazing ‘after’

Uncover your Hidden Beauty

Every journey begins with a single step—today is the day

At Yafa Health, we offer a weight management treatment using compounded GLP-1, which is a once-weekly subcutaneous injection that you can do at home at your own convenience. We recommend setting a weekly reminder for your injection and pairing it with other healthy habits, such as a balanced healthy diet and regular exercise activities. This integrated approach can enhance the overall benefits of the treatment.

Stronger, healthier, happier,

one step at a time

Many patients have reported significant weight loss and improved blood sugar control with compounded GLP-1. They reported increased energy levels, reduced food cravings, and overall improvement in their well-being. Patients also appreciate the convenience of a once-weekly injection, which fits easily into their busy lives.

Take the first step

Call us today to learn how our program can help you, and let's start your transformation together. Your health matters, so why wait?

You can call us at 978-668 4949, leave us a message if the line is busy & we will call you back. You can also fill out our online Contact Us form with your contact information, and we will contact you within 24-48 hrs.

Page updated

Google Sites

Report abuse